Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
NCT ID:
NCT00436995
Eligibility Criteria:
Inclusion Criteria:
* Receiving dialysis for 3 months or more before enrollment.
* The mean of 2 screening Hb values taken at least 7 days appart must be greater than or equal to 11g/dL and less than or equal to 13.0 g/dL
* Receiving stable QW darbepoetin alfa doses for at least 6 weeks before enrollment
* Adequate iron stores (serum ferritin equal to or greater than 100 ug/L
Exclusion Criteria:
* Uncontrolled hypertension
* Prior history of Cardiovascular Incidents 12 weeks prior to enrollment
* Other hematological disorders
* Upper or lower GI bleed within the prior 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00436995
Study Brief:
Protocol Section:
NCT00436995